Home/ Supplements/ Nattokinase/ Nattozimes 65 mg

Nattozimes 65 mg

product on market Capsule Swanson
Label

Product Label

Label for Nattozimes 65 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

Non-Nutrient/Non-Botanical
Product Type
Ingredients

Supplement Facts

Nattozimes
Rice Bran
Hypromellose
Dextrin
Maltodextrin
Medium Chain Triglyceride, Powder
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Metadata

Product Details

DSLD Entry Date2024-11-22
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
BrandSwanson
DSLD ID322738
Data Updated2026-04-10
Research

Research Evidence

4
Research Sources
45
Avg Quality
2
Rct
1
Other
1
Systematic Review
B Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Systematic Review Reviews in cardiovascular medicine 2023 PubMed DOI
C Effects of nattokinase on blood pressure: a randomized, controlled trial
Rct Hypertension research : official journal of the Japanese Society of Hypertension 2008 PubMed DOI
C A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles
Rct Scientific reports 2015 PubMed DOI
D [A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia]
Other Zhonghua yi xue za zhi 2017 PubMed DOI
View all evidence for Nattokinase →
Compare

Similar Products

View all Nattokinase products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.